Skip to content

nejmHimmelfarb Library provides access to the latest clinical information via sources such as DynaMed Plus, ClinicalKey, and Lexicomp which complement our extensive journal collection.   To enhance learning, users can also take advantage of multimedia content designed to help clinicians, residents and students master skills and test knowledge.  Himmelfarb Library's online subscription to the New England Journal of Medicine includes access to:

 

 

This month, the Genetics Journal Club features a double-blind randomized clinical trial which compared the use of a third-generation irreversible EGFR-TKI (osimertinib) versus standard therapy (gefitinib or erlotinib) to treat non small-cell lung cancer.  You can read the results of this study in the New England Journal of Medicine.

Soria, J. C., Ohe, Y., Vansteenkiste, J., Reungwetwattana, T., Chewaskulyong, B., Lee, K. H., ... & Okamoto, I. (2017). Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine.

To learn more about EGFR mutations in non small-cell lung cancer, explore additional readings from Himmelfarb Library's full-text collection:

Explore more of Himmelfarb Library's genetics collection by checking out:

 That is the question now being considered in light of a new research article in the New England Journal of Medicine in which a new gene therapy drug was given to men with hemophilia B.  After receiving the new drug, the patients were able to stop using clotting factors to treat their hemophilia.  Patients rates of bleeding also fell - from about 11 bleeding events per year to less than one bleeding event per year.  Learn more about the research here:

Explore genetics topics via the Genetics Journal Club and Himmelfarb Library's genetics collection by checking out:

pharmacogenomics-2316521_960_720

  • Is this drug more effective for individuals with a specific genetic profile?  
  • Are some people at increased risk of a serious drug reaction from a specific drug?  
  • How is pharmacogenomic information being used clinically right now?

Pharmacogenomics: Precision Medicine and Drug Response, a new CME review article from the Mayo Clinic Proceedings, explores these issues.  This article provides a brief history of pharmacogenomics, information on current clinical applications, and conceptualizes the future of pharmaceogenomics.

This article is available online via ClinicalKey which is part of Himmelfarb Library's online collection.  To read more about genetics, check out these full-text e-books in ClinicalKey

To explore more genetics topics, check out Dr. Charles Macri's online Genetics Journal Club!

maternalchildHow will proposed changes to health care law affect women's health in the United States?

A new article in Women's Health Issues explores this issue.  In The Risk of Remaining Silent: Addressing the Current Threats to Women's Health, the authors assess how changes to the Affordable Care Act, insurance coverage for contraception, Planned Parenthood, and additional Department of Health and Human Services programs might affect health care for women.
Dr. Claire Brindis from the University of California, San Francisco is the first author in this paper.  The George Washington University's Dr. Amita Vyas is the editor for Women's Health Issues and is also the program director of the Maternal and Child Health Program in GW's Milken Institute School of Public Health.

scholarGoogle Scholar recently made some interface updates and so may look a bit different, but still offers Himmelfarb Library users some great options to customize the search interface.    Many of the customization options are available from the menu in the very upper left portion of the screen (three horizontal lines); the Settings option available there will allow you to:

  • Search Results: in the Bibliography Manager section, change the 'Show links to import citations into' to RefWorks.
  • Library Links: if you're off-campus, search for George Washington and add the full-text links for Himmelfarb Library to improve your access to full-text articles.

Google Scholar also revamped the Cite and Save options.  These options appear under each citation, moved left, and are now represented by icons rather than text.  The Cite option is available under the quote marks icon, and the Save option is available via the star icon.

genomeWhile evidence has suggested that this is true, the first study identifying specific genetic factors that exist in women with preterm deliveries was just published in the New England Journal of Medicine.  This study used data from nearly 50,000 women and identified specific genetic variations which can predict length of gestation and risk of preterm birth.

Image citation: Ricciardi, R. (2013). Human genome [online image].  Available at:  https://www.flickr.com/photos/ricricciardi/11622986115

maryclairekingThing you are having a challenging week?
Listen to Dr. Mary-Claire King describe one week in her life.  Dr. King's research identified the BRCA1, a gene that increases the risk for breast cancer, among many other accomplishments.
King M. Who can you trust? The Moth Web site. http://themoth.org/stories/who-can-you-trust. Updated 2014. Accessed Sep 18, 2017.
You can read Dr. King's research findings by searching PubMed and linking to full-text articles in Himmelfarb Library's collection.  Here is a sample of three articles from the different subjects she has studied:

 

Can a blood test be used to screen for cancer? 

This question was addressed in a recent NEJM article which investigated if checking for the Epstein-Barr virus (EBM) in plasma samples would be a useful screening test for nasopharyngeal carcinoma in patients with no symptoms of the disease. 

To understand how this prospective study was conducted and learn about the results, read the article or watch the NEJM's quick take video:

 
Check out additional articles on genetics research in Dr. Charles Macri's online Genetics Journal Club.